These points you raise are indeed excellent and perhaps worthy enough to be submitted to management for addressing at our AGM or writing to them with your concerns and just see what their reply is. My opinion is, they certainly have performed well enough for me, at this stage, and they would have taken all this into play in strategising their commercialisation program. Don't forget, RAP has been proactive in engaging/employing the right professionals to do this. We have seen this in evidence with the left-field announcements, which is not the work of just one or two high-profile company people doing the 'rounds on the international stage, even though we give them (BL & TK) the credit, moreover as we all know, it is a team effort. I have got my eye on the prize, just as everyone at RESAPP Health has I'm sure...
- Forums
- ASX - By Stock
- RAP
- A new Beginning...
A new Beginning..., page-3088
-
-
- There are more pages in this discussion • 361 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online